Sitaglu Met 50/500mg Tablet (28s) – Effective Dual Therapy for Type 2 Diabetes Control
Sitaglu Met 50/500mg Tablet (28s) – Effective Dual Therapy for Type 2 Diabetes Control
Description
Sitaglu Met 50/500mg Tablet – Balanced Combination for Improved Blood Sugar Regulation
Sitaglu Met 50/500mg Tablet combines sitagliptin 50mg and metformin hydrochloride 500mg to offer comprehensive dual-action management for adults with type 2 diabetes. Sitagliptin, a DPP-4 inhibitor, prolongs the activity of incretin hormones to enhance insulin secretion and suppress glucagon when blood glucose is high, while metformin reduces hepatic glucose production and improves insulin sensitivity. This synergistic blend provides effective lowering of HbA1c, fasting, and post-meal blood sugar levels with a convenient fixed-dose format.
Ideal for patients not adequately controlled on metformin alone or those benefiting from combination therapy, this twice-daily tablet supports consistent glycemic control when used with diet and exercise under medical guidance.
